SCHEMBL7962844

SCHEMBL7962844

NCCCCN1CCc2cc(C(F)(F)F)ccc2C1

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.45
DRD3 P35462 3/20 0.43
DRD2 P14416 2/20 0.43
HTR7 P34969 6/20 0.43
HTR1A P08908 2/20 0.40
HTR2A P28223 1/20 0.40
SLC6A4 P31645 1/20 0.40
HRH1 P35367 1/20 0.40
HTR2B P41595 1/20 0.40
ABCB1 P08183 1/20 0.40
GRM2 Q14416 1/20 0.40
PNMT P11086 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6980960 0.95 DRD3 (0.43) ACACBDRD3DRD2HTR7HTR1A
SCHEMBL4390014 0.85 ACACB (0.51) ACACBDRD3DRD2HTR7HTR1A
SCHEMBL7973100 0.81 ACACB (0.48) ACACBDRD3DRD2HTR7HTR1A
SCHEMBL4382326 0.80 ACACB (0.46) ACACBDRD3DRD2HTR7HTR1A
SCHEMBL7979148 0.79 CARM1 (0.49) ACACBDRD3DRD2HTR7SLC6A4
SCHEMBL16624019 0.79 ACACB (0.52) ACACBDRD3DRD2PNMT
SCHEMBL29964619 0.79 ACACB (0.49) ACACBDRD3DRD2
SCHEMBL7979139 0.78 DRD3 (0.49) ACACBDRD3DRD2
SCHEMBL7634391 0.77 ACACB (0.42) ACACBDRD3DRD2SLC6A4
SCHEMBL8151957 0.77 DRD2 (0.46) ACACBDRD3DRD2HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274593-B1 TREATING PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA, AND PARKINSON*S DISEASE SMITHKLINE BEECHAM P.L.C. (GB) 2001-08-14 US disclosed
EP-0980357-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 2000-02-23 EP disclosed
WO-1998050363-A1 SUBSTITUTED TETRAHYDRO ISOQUINOLINES AS MODULATORS OF DOPAMINE D3 RECEPTORS SMITHKLINE BEECHAM PLC (GB) 1998-11-12 WO disclosed